05:05 PM EDT, 03/25/2024 (MT Newswires) -- Innocan Pharma Corporation ( INNPF ) , a pioneer in the development of drug delivery technologies using CBD for the pharmaceutical and biotechnology industries, announced Monday the signing of an agreement with the Hebrew University, which facilitate Innocan to initiate the Food and Drug Administration (FDA) approval process for its liposome CBD platform (LPT-CBD) in accordance with FDA's Chemistry Manufacturing Control (CDC) Guidelines.